Overview
Strengthening outpatient low respiratory tract infection surveillance to document the burden of Respiratory Syncytial Virus (RSV)
Description
The study protocol is designed with three key components: 1. Build on existing PARI outpatient syndromic surveillance by adding laboratory multiplex testing of LRTI samples (RSV, Influenza, SARS-COV-2) 2. Follow all bronchiolitis through the PARI RWE database and document "patient journey" for 5 years after first medical visit 3. Review the electronic PARI data of three previous seasons in order to document the impact of LRTI attributable to RSV in children \< 2 years in France prior to enhanced surveillance
Eligibility
Inclusion Criteria:
- children under 24 months of age (≤)
- One of the holders of parental authority signed the consent
- Patient affiliated to a social security scheme (Social Security or Universal Medical Coverage)
- Acute purulent otitis media (Paradise Criteria) or otorrhea with or withitout associated bronchiolitis
Exclusion Criteria:
- Age \>24 months
- Refusal by one of the parents
- Not affiliated to a social security system
- Maternal RSV vaccination during the pregnancy of the included child
